Press release
Radiodermatitis Market Is Expected To Reach $442.1 Million By 2025: Grand View Research, Inc.
The global radiodermatitis market is expected to reach USD 442.1 million by 2025, according to a new report by Grand View Research, Inc. The global radiodermatitis market is expected to grow at an unprecedented rate owing to the growing prevalence of cancer patients undergoing radiation therapy. The demand for radiodermatitis treatment is also accentuated by unmet medical needs of consumers in emerging as well as developed regions. Increasing focus of government healthcare organizations for promoting awareness about available treatment products for radiodermatitisis predicted to present the market with high potential growth opportunities.In addition, increasing R&D activities in the area of life sciences is presumed to be one of the significant factors contributing toward growth of this market. For instance, in December 2016, Mölnlycke Health Care AB entered into a licensing agreement with a Texas-based R&D company Rochal Industries. This agreement was carried out to reinforce its position as a prevention solutions firm. In addition, they have signed a joint agreement to enhance their R&D capabilities and commercialize new patented technological platforms.Other factors such as escalating number of product launches with respect to radiodermatitis treatment and increasing demand for these products are expected to boost the overall market growth.
Browse full research report on Global Radiodermatitis Market: (http://www.grandviewresearch.com/industry-analysis/radiodermatitis-market)
Further key findings from the report suggest:
• Topical products captured the largest share in the product segment in 2016. The dominant share is attributable to ease in availability, greater convenience, and superiority over oral products
• Topical products are also anticipated to grow at an exponential rate owing to their availability in various formulations such as creams, gels, and ointments according to the requirement of the patient
• In 2016, retail pharmacy accounted for the substantial share of the distribution channel segment as a consequence of ease in availability and high convenience associated with it.
• Asia Pacific held the largest share of the radiodermatitis market owing to presence of a large cancer patient base present across this region
• North America held the secondlargest share owing to extensive R&D activities that have fueled high potential growth opportunities
• In addition, availability of therapeutically advanced products across North America is one of the major factors contributing toward itshighshare
• The competition is marked by major players undertaking strategies such as product launches, distribution agreements, and strategic collaborations that haveled to significant growth in their respective market share
Grand View Research has segmented the global radiodermatitis market on the basis of product, distribution channel, and region:
Radiodermatitis Product Outlook (Revenue, USD Million, 2014 - 2025)
• Topical
o Corticosteroids
o Hydrophilic Creams
o Antibiotics
o Others
• Oral
• Dressings
o Hydrogel & Hydrocolloid Dressings
o No Sting Barrier Film
o Honey-Impregnated Gauze
o Silicone-Coated Dressings
o Others
Radiodermatitis Distribution Channel Outlook (Revenue, USD Million, 2014 - 2025)
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacies
Radiodermatitis Regional Outlook (Revenue, USD Million, 2014 - 2025)
• North America
o U.S.
o Canada
• Europe
o UK
o Germany
• Asia Pacific
o Japan
o China
o India
• Latin America
o Brazil
o Mexico
• Middle East & Africa
o South Africa
For more information: www.grandviewresearch.com
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Press Contact
Sherry James - Corporate Relations Specialist
28 2nd Street, Suite 3036
San Francisco, CA 94105
United States
Phone: 1-415-349-0058
Email: sales@grandviewresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Radiodermatitis Market Is Expected To Reach $442.1 Million By 2025: Grand View Research, Inc. here
News-ID: 597248 • Views: …
More Releases from Grand View Research, Inc.

Generative AI Market Size, Share, And Industry Outlook Report, 2030
Generative AI Market Growth & Trends
The global generative AI market size is anticipated to reach USD 109.37 billion by 2030, according to a new report by Grand View Research, Inc., registering a CAGR of 37.6% from 2025 to 2030. Growing demand to modernize workflow across industries is expected to drive the demand for generative AI applications among industries. Other factors that propel the market growth include the evolution of AI…

Maternal Mental Health Market To Reach $45.72 Billion By 2030 | Therapy Mama, Ca …
The global maternal mental health market size is expected to reach USD 45.72 billion by 2030, growing at a CAGR of 28.43%, according to a new report by Grand View Research, Inc. Maternal mental health issues are a global concern that affects women of various countries and cultures. It refers to the emotional well-being of women during the pregnancy and postpartum period. The market is driven by the increasing incidence…

Downstream Processing Market Size, Share & Trends Analysis Report, 2030
The global downstream processing market size is expected to reach USD 94.79 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 14.84% from 2023 to 2030. The capacity requirements during the development of biologic drugs have changed over the past few years, wherein the demand for manufacturing high-volume products has shifted to developing small-volume, high-potency…

Electric Mobility Industry: E- Light Commercial Vehicle Thereby Contributing To …
The global electric mobility industry size stood at USD 101.67 billion in 2022 and will exhibit a CAGR of 19.9% from 2023 to 2030, according to the "Electric Mobility Industry Data Book, 2023 - 2030," published by Grand View Research. The growth comes on the back of an exponential rise in smart cities and a gradual uptick in charging infrastructure. Further, the strong outlook of electric mobility will rely on the launch…
More Releases for Radiodermatitis
Radiodermatitis Market
Radiodermatitis Market report, published by DataM Intelligence, delivers detailed insights and analysis on major market trends, growth prospects, and emerging challenges. With a strong focus on providing actionable intelligence, DataM Intelligence enables businesses to make well-informed decisions and maintain a competitive edge. By blending both qualitative and quantitative research approaches, the company offers thorough reports that support clients in navigating complex market environments, driving strategic expansion, and capitalizing on new…
Radiodermatitis Market to Witness Comprehensive Growth by 2027
The latest professional intelligence study by the Transparency Market Research (TMR) predicts that the global radiodermatitis market will rise to record a CAGR of 3.3% over the forecast period of 2019 to 2027. Furthermore, the study also projects that the market will grow from its initial evaluation of US$ 334.2 Mn in base year of the study,2018, and reach the final value of US$ 334.2 Mn by the end of…
Radiodermatitis Market Survey Report 2019-2027
Transparency Market Research (TMR) has published a new report titled, 'Radiodermatitis Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019-2027'. According to the report, the global Radiodermatitis market was valued at US$ 334.2 Mn in 2018 and is projected to expand at a CAGR of 3.3% from 2019 to 2027.
Get Sample Copy of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2157
Overview
• Radiodermatitis, alternatively known as radiation dermatitis, is a condition caused by…
Radiodermatitis Treatment Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Radiodermatitis Treatment Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Radiodermatitis Treatment players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Radiodermatitis Treatment with respect to individual growth…
Radiodermatitis Market: Emerging Growth Factors and Forecasts 2024
The global radiodermatitis market is consolidated, with the top five players accounting for a share of just over 47% in 2015. These are 3M Healthcare, Smith & Nephew plc, Molnlycke Health Care, Acelity, and Convatec, Inc. Transparency Market Research finds that success in the radiodermatitis market is dependent on the ability of pharma and medical device companies to develop innovative products that can address unmet consumer needs and also help…
Radiodermatitis Market Research Report | Forecast 2024
The global radiodermatitis market is consolidated, with the top five players accounting for a share of just over 47% in 2015. These are 3M Healthcare, Smith & Nephew plc, Molnlycke Health Care, Acelity, and Convatec, Inc. Transparency Market Research finds that success in the radiodermatitis market is dependent on the ability of pharma and medical device companies to develop innovative products that can address unmet consumer needs and also help…